Because the drug doesn’t target the brain, it has less potential for addiction. Learn why this could help the opioid crisis.
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
Hosted on MSN54m
FDA approves non-opioid painkillerWhite House Press Secretary Karoline Leavitt told reporters that President Trump would be implementing tariffs on Canada, ...
This new nonaddictive alternative is the first of its kind that interrupts the pain signal before it reaches the brain.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback